Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec;20(6):213.
doi: 10.3892/etm.2020.9342. Epub 2020 Oct 14.

Recent advances in surface-enhanced Raman spectroscopy based liquid biopsy for colorectal cancer (Review)

Lucretia Avram  1 , Andrei Stefancu  2 , Dana Crisan  3 , Nicolae Leopold  2   4 , Valer Donca  1 , Elena Buzdugan  3 , Rares Craciun  3 , David Andras  5 , Ioan Coman  6
Affiliations
Review

Recent advances in surface-enhanced Raman spectroscopy based liquid biopsy for colorectal cancer (Review)

Lucretia Avram et al. Exp Ther Med. 2020 Dec.

Abstract

As colorectal cancer (CRC) is one of the forms of cancer with the highest prevalence globally and with a high mortality, screening and early detection remains a major issue. Colonoscopy is still the gold standard for detecting premalignant lesions, but it is burdened by some complications. For instance, it is laborious, with some difficulties of acceptance for some patients, and is ultimately an imperfect standard, given that some premalignant lesions or incipient malignancies can be missed by colonoscopic evaluation. In this context, new non-invasive approaches such as surface-enhanced Raman spectroscopy (SERS) based liquid biopsy have gained ground in recent years, showing promising results in oncological pathology diagnosis. These new methods have enabled the detection of subtle molecular profile alterations prior to any macroscopic morphological changes, thus providing a useful tool for early CRC detection. In the present review, we provide a summary of published studies applying SERS in CRC detection, along with our personal experience in using SERS in the diagnosis of different oncological pathologies, including CRC.

Keywords: Raman; SERS; colorectal cancer; liquid biopsy; nanoparticles.

PubMed Disclaimer

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Wolf AMD, Fontham ETH, Church TR, Flowers CR, Guerra CE, LaMonte SJ, Etzioni R, McKenna MT, Oeffinger KC, Shih YT, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68:250–281. doi: 10.3322/caac.21457. - DOI - PubMed
    1. Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: Systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ. 2014;348(g2467) doi: 10.1136/bmj.g2467. - DOI - PMC - PubMed
    1. Kim NH, Jung YS, Jeong WS, Yang HJ, Park SK, Choi K, Park DI. Miss rate of colorectal neoplastic polyps and risk factors for missed polyps in consecutive colonoscopies. Intest Res. 2017;15:411–418. doi: 10.5217/ir.2017.15.3.411. - DOI - PMC - PubMed
    1. Fernández-Lázaro D, García Hernández JL, García AC, Córdova Martínez A, Mielgo-Ayuso J, Cruz-Hernández JJ. Liquid biopsy as novel tool in precision medicine: Origins, properties, identification and clinical perspective of cancer's biomarkers. Diagnostics (Basel) 2020;10(215) doi: 10.3390/diagnostics10040215. - DOI - PMC - PubMed